20-36431833-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001365621.2(DLGAP4):c.116C>T(p.Ala39Val) variant causes a missense change. The variant allele was found at a frequency of 0.000604 in 1,613,822 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001365621.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DLGAP4 | NM_001365621.2 | c.116C>T | p.Ala39Val | missense_variant | Exon 3 of 13 | ENST00000339266.10 | NP_001352550.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DLGAP4 | ENST00000339266.10 | c.116C>T | p.Ala39Val | missense_variant | Exon 3 of 13 | 5 | NM_001365621.2 | ENSP00000341633.5 | ||
DLGAP4 | ENST00000373913.7 | c.116C>T | p.Ala39Val | missense_variant | Exon 3 of 13 | 1 | ENSP00000363023.3 | |||
DLGAP4 | ENST00000373907.6 | c.116C>T | p.Ala39Val | missense_variant | Exon 2 of 12 | 5 | ENSP00000363014.2 |
Frequencies
GnomAD3 genomes AF: 0.000526 AC: 80AN: 152184Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000379 AC: 94AN: 248196Hom.: 0 AF XY: 0.000357 AC XY: 48AN XY: 134362
GnomAD4 exome AF: 0.000612 AC: 895AN: 1461638Hom.: 0 Cov.: 31 AF XY: 0.000620 AC XY: 451AN XY: 727134
GnomAD4 genome AF: 0.000526 AC: 80AN: 152184Hom.: 0 Cov.: 32 AF XY: 0.000390 AC XY: 29AN XY: 74350
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.116C>T (p.A39V) alteration is located in exon 2 (coding exon 1) of the DLGAP4 gene. This alteration results from a C to T substitution at nucleotide position 116, causing the alanine (A) at amino acid position 39 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at